3月11日,康龙化成(300759/03759)发布公告,近日公司通过全资子公司Pharmaron (HongKong) International Limited对合资公司PharmaGend Global Medical Services Pte. Ltd. 追加投资1050万美元的事项取得进展。该投资的备案已获得北京市发展和改革委员会、北京市商务局等主管单位的批准,并且所有投资人已向合资公司...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.